| 1 |
Merisko-Liversidge, E., Liversidge, G.G. and Cooper, E.R. (2003), "Nanosizing: A formulation approach for poorly-water-soluble compounds", Eur. J. Pharm. Sci., 18(2), 113-120.
DOI
|
| 2 |
Moghimi, S.M. and Hunter, A.C. (2000), "Poloxamers and poloxamines in nanoparticle engineering and experimental medicine", Trends Biotechnol., 18(10), 412-420.
DOI
|
| 3 |
Agueros, M., Zabaleta, V., Espuelas, S., Campanero, M.A. and Irache, J.M. (2010), "Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles", J. Control. Release, 145(1), 2-8.
DOI
|
| 4 |
Moschwitzer, J.P. (2013), "Drug nanocrystals in the commercial pharmaceutical development process", Int. J. Pharmaceutics, 453(1), 142-156.
DOI
|
| 5 |
Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2001), "Long-circulating and target-specific nanoparticles: Theory to practice", Pharmacol. Rev., 53(2), 283-318.
|
| 6 |
Moghimi, S.M. and Szebeni, J. (2003), "Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties", Prog. Lipid Res., 42(6), 463-478.
DOI
|
| 7 |
Molento, M.B. (2009), "Parasite control in the age of drug resistance and changing agricultural practices", Vet Parasitol, 163(3), 229-334.
DOI
|
| 8 |
Mozarafi, M.R. (2005), "Liposomes: An overview of manufacturing techniques", Cell. Mol. Biol. Lett., 10, 711-719.
|
| 9 |
Muller, T. (2001), "Identification of plant-associated enterococci", J. Appl. Microbiol., 91(2), 268-278
DOI
|
| 10 |
Muller, R.H., Radtke, M. and Wissing, S.A. (2002), "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations", Adv. Drug Deliv. Rev., 54, S131-S155.
DOI
|
| 11 |
Munn, L.L. (2003), "Aberrant vascular architecture in tumours and its importance in drug-based therapies", Drug Discov. Today, 8(9), 396-403.
DOI
|
| 12 |
Allison, A.C. and Gregoriadis, G. (1974), "Liposomes as immunological adjuvants", Nature, 252, 252.
|
| 13 |
Alam, S., Pandai, J.J., Mukherjee, T.K. and Chauhan, V.S. (2016), "Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria", J. Nanobiotechnol., 14, 26. DOI: 10.1186/s12951-016-0179-8
DOI
|
| 14 |
Allahverdiyev, A.M., Bagirova, M., Abamor, E.S., Ates, S.C., Koc, R.C., Miraloglu, M., Elcicek, S., Yaman, S. and Unal, G. (2013), "The use of platensimycin and platencin to fight antibiotic resistance", Infect. Drug Resist., 6, 99-114.
|
| 15 |
Allemann, E., Gurnay, R. and Doelker, E. (1992), "Preparation of aqueous polymeric nanodispersions by a reversible salting-out process, influence of process parameters on particle size", Int. J. Pharm., 87(1-3), 247-253.
DOI
|
| 16 |
Ambruosi, A., Yamamoto, H. and Kreuter, J. (2005), "Body distribution of polysorbate-80 and doxorubicinloaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats", J. Drug Target., 13, 535-542.
DOI
|
| 17 |
Arangoa, M.A., Campanero, M.A., Renedo, M.J., Ponchel, G. and Irache, J.M. (2001), "Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationship between bioadhesion and pharmacokinetics", Pharm. Res., 18(11), 1521-1527.
DOI
|
| 18 |
Berton, M., Turelli, P., Trono, D., Stein, C.A., Allemann, E. and Gurny, R. (2001), "Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles", Pharm. Res., 18(8), 1096-1101.
DOI
|
| 19 |
Nagpal, K., Singh, S.K. and Mishra, D.N. (2016), "Chitosan nanoparticles: A promising system in novel drug delivery", Chem. Pharm. Bull. (Tokyo), 58(11), 1423-1430.
DOI
|
| 20 |
Murillo, M., Gamazo, C., Irache, J.M. and GoNi, M.M. (2002), "Polyester microparticles as a vaccine delivery system for brucellosis: Influence of the polymer on release, phagocytosis and toxicity", J. Drug Target., 10(3), 211-219.
DOI
|
| 21 |
Nahar, M. and Jain, N.K. (2009), "Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles", Pharm. Res., 26, 2588-2598.
DOI
|
| 22 |
Niwa, T., Takeuchi, H., Hino, T., Kunou, N. and Kawashima, Y. (1993), "Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with dl-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour", J. Controlled Release, 25(1-2), 89-98.
DOI
|
| 23 |
Bhushan, B. (2010), "Nanomechanical characterization of skin and skin cream", J. Microscopy, 240(2), 135-144.
DOI
|
| 24 |
Bielinska, A.U., Kukowska-Latallo, J.F., Johnson, J., Tomalia, D.A. and Baker, J.R. (1996), "Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers", Nucleic Acids Res., 24(11), 2176-2182.
DOI
|
| 25 |
Nayak, B., Panda, A.K., Ray, P. and Ray, A.R. (2009), "Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination", J. Microencapsul., 26(2), 154-165.
DOI
|
| 26 |
Nechaeva, E.A., Varaksin, N., Ryabicheva, T., Smolina, M., Kolokoltsova, T., Vilesov, A., Aksenova, N., Stankevich, R. and Isidorov, R. (2001), "Approaches to development of microencapsulated form of the live measles vaccine", Ann. N. Y. Acad. Sci., 944, 180-186.
|
| 27 |
Nechaeva, E. (2002), "Development of oral microencapsulated forms for delivering viral vaccines", Exp. Rev. Vaccines, 1(3), 385-397.
DOI
|
| 28 |
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T. and Maeda, H. (1998), "Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues", Jpn. J. Cancer Res., 89(3), 307-314.
DOI
|
| 29 |
Birrenbach, G. and Speiser, P.P. (1976), "Polymerized micelles and their use as adjuvants in immunology", J. Pharm. Sci., 65(12), 1763-1766.
DOI
|
| 30 |
Birrenbach, G. (1973), "Uber Mizellpolymerisate, mogliche Einschlussverbindungen (Nanokapseln) und deren Eignung als Adjuvantien", Ph.D. Thesis, Dissertation; ETH Nr. 5071.
|
| 31 |
Bivas-Benita, M., Lin, M.Y., Bal, S.M., van Meijgaarden, K.E., Franken, K.L., Friggen, A.H., Junginger, H.E., Borchard, G., Klein, M.R. and Ottenhoff, T.H. (2009), "Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice", Vaccine, 27(30), 4010-4017.
DOI
|
| 32 |
Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewit, J., De, B.J., Jongert, E. and Borchard, G. (2003), "Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies", Int. J. Pharm., 266(1-2), 17-27.
DOI
|
| 33 |
Borges, O., Tavares, J., de Sousa, A., Borchard, G., Junginger, H.E. and Cordeiroda-Silva, A. (2007), "Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles", Eur. J. Pharm. Sci., 32(4-5), 278-290.
DOI
|
| 34 |
Bottomley, K. (2006), "Nanotechnology for drug delivery: A validated technology?", Drug Deliv. Rep. (Autumn/Winter), 20-21.
|
| 35 |
Oowaki, H., Matsuda, S., Sakai, N., Ohta, T., Iwata, H., Sadato, A., Taki, W., Hashimoto, N. and Ikada, Y. (2000), "Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery", Drug Deliv Transl Res., 21(10), 1039-1046. URL: http://link.springer.com/article/10.1007%2Fs13346-016-0290-2
|
| 36 |
Noyes, A.A. and Whitney, W.R. (1897), "The rate of solution of solid substances in their own solutions", J. Am. Chem. Soc., 19(12), 930-934.
DOI
|
| 37 |
Lipinski, C.A. (2002), "Single-mode compound retrieval for QSAR, QSPR data sets, and batch mode exact structure searching", J. Pharm. Sci., 91(12), 2470-2472.
DOI
|
| 38 |
Ojer, P., Salman, H., Da Costa Martins, R., Calvo, J., Lopez de Cerain, A., Gamazo, C., Lavandera, J.L. and Irache, J.M. (2010), "Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery", J. Drug Deliv. Sci. Technol., 20(5), 353-359.
DOI
|
| 39 |
Boudad, H., Legrand, P., Appel, M., Coconier, M.H. and Ponchel, G. (2001), "Formulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir", STP Pharm. Sci., 11(5), 369-375.
|
| 40 |
Bowman, K. and Leong, K.W. (2006), "Chitosan nanoparticles for oral drug and gene delivery", Int. J. Nanomed., 1(2), 117-128.
DOI
|
| 41 |
Paleos, C.M., Sideratou, Z., Kontoyianni, C. and Drossopoulou, G.I. (2010), "Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system", Bioorg. Med. Chem. Lett., 20(22), 6513-6517.
DOI
|
| 42 |
Ringsdorf, H. (1975), "Structure and properties of pharmacologically active polymers", J. Polym. Sci., C Polym. Symp., 51(1), 135-153.
|
| 43 |
Sakthivel, T. and Florence, A.T. (2003), "Adsorption of amphipathic dendrons on polystyrene nanoparticles", Int. J. Pharm., 254(1), 23-26.
DOI
|
| 44 |
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J.P. and Couvreur, P. (1990), "Hepatic tissue distribution of doxorubicin loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice", Cancer Chemother. Pharmacol., 26(2), 122-126.
DOI
|
| 45 |
Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S. and Saettone, M.F. (2002), "Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin", Int. J. Pharm., 238(1-2), 241-245.
DOI
|
| 46 |
Chen, S.C., Jones, D.H., Fynan, E.F., Farrar, G.H., Clegg, J.C., Greenberg, H.E. and Herrmann, J.E. (1998), "Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles", J. Virol., 72(7), 5757-5761.
|
| 47 |
Cheng, Y. and Xu, T. (2005), "Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers", Eur. J. Med. Chem., 40(11), 1188-1192.
DOI
|
| 48 |
Conway, M.A., Madrigal-Estebas, L., McClean, S., Brayden, D.J. and Mills, K.H. (2001), "Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: Effect of formulation and route of immunization on induction of Th1 and Th2 cells", Vaccine, 19(15-16), 1940-1950.
DOI
|
| 49 |
Cossart, P. (2004), "Bacterial invasion: A new strategy to dominate cytoskeleton plasticity", Dev. Cell, 6(3), 314-315.
DOI
|
| 50 |
Santhoshkumar, T., Rahuman, A.A., Bagavan, A., Marimuthu, S., Jayaseelan, C., Kirthi, A.V., Kamaraj, C., Rajakumar, G., Zahir, A.A., Elango, G., Velayutham, K., Iyappan, M., Siva, C., Karthik, L. and Rao, K.V. (2012), "Evaluation of stem aqueous extract and synthesized silver nanoparticles using Cissus quadrangularis against Hippobosca maculata and Rhipicephalus (Boophilus) microplus", Exp Parasitol., 132(2), 156-165.
DOI
|
| 51 |
Santos-Magalhães, N.S. and Morsqueira, V.C. (2010), "Nanotechnology applied to the treatment of malaria", Adv. Drug Deliv. Rev., 62(4-5), 560-575.
DOI
|
| 52 |
Storni, T., Kundig, T.M., Senti, G. and Johansen, P. (2005), "Immunity in response to particulate antigendelivery systems", Adv. Drug Deliv. Rev., 57(3), 333-355
DOI
|
| 53 |
Sun, L., Zhang, S., Sun, X. and He, X. (2010), "Effect of the geometry of the anodized titania nanotube array on the performance of dye-sensitized solar cells", J. Nanosci. Nanotechnol., 10(7), 4551-4561.
DOI
|
| 54 |
Svenson, S. and Tomalia, D.A. (2005), "Dendrimers in biomedical applications--reflections on the field", Adv. Drug Deliv. Rev., 57(15), 2106-2129.
DOI
|
| 55 |
Couvreur, P., Gref, R., Andrieux, K. and Malvy, C. (2006), "Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases", Prog. Solid State Chem., 34(2-4), 231-235.
DOI
|
| 56 |
Couvreur, P., Kante, B., Roland, M., Guiot, P., Baudin, P. and Speiser, P. (1979), "Polycyanoacrylate nanocapsules as potential lysosomotropic carriers-preparation, morphological and sorptive properties", J. Pharm. Pharmacol., 31(1), 331-332.
DOI
|
| 57 |
Couvreur, P. and Puisieux, F. (1993), "Nano-and micro-particles for the delivery of polypeptides and proteins", Adv. Drug Deliv. Rev., 10(2-3), 141-162.
DOI
|
| 58 |
Thakkar, A., Chenreddy, S., Thio, A., Khamas, W., Wang, J. and Prabhu, S. (2016), "Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice", Int. J. Nanomedicine, 11, 3265-3276.
DOI
|
| 59 |
Tros de Ilarduya, C., Sun, Y. and Duzgunes, N. (2010), "Gene delivery by lipoplexes and polyplexes", Eur. J. Pharm. Sci., 40(3), 159-170.
DOI
|
| 60 |
Couvreur, P., Barratt, G., Fattal, E. Legrand, P. and Vauthier, C. (2002), "Nanocapsule technology: A review", Crit. Rev. Ther. Drug Carrier Syst., 19(2), 99-134.
DOI
|
| 61 |
Couvreur, P. and Vauthier, C. (2006), "Nanotechnology: Intelligent design to treat complex disease", Pharm. Res., 23(7), 1417-1450.
DOI
|
| 62 |
Cronkhite, R.I. and Michael, J.G. (2004), "Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties", Vaccine, 22(17-18), 2106-2115.
DOI
|
| 63 |
Croy, S.R. and Kwon, G.S. (2006), "Preparation of small-sized particles from vicilin (vegetal protein from Pisum sativum L.) by coacervation", Eur. J. Pharm. Biopharm., 42(1), 36-41.
|
| 64 |
D'Emanuele, A. and Attwood, D. (2005), "Dendrimer-drug interactions", Adv. Drug Deliv. Rev., 57(15), 2147-2162.
DOI
|
| 65 |
Ekman, P. and Friesen, W.V. (1976), Pictures of Facial Affect, Consulting Psychologists, Palo Alto, CA, USA.
|
| 66 |
Fattal, E., Youssef, M., Couvreur, P. and Andremont, A. (1989), "Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles", Antimicrob. Agents Chemother., 33(9), 1540-1543.
DOI
|
| 67 |
Waknine-Grinberg, J.H., Even-Chen, S., Avichzer, J., Turjeman, K., Bentura-Marciano, A., Haynes, R.K., Weiss, L., Allon, N., Ovadia, H., Golenser, J. and Barenholz, Y. (2013), "Glucocorticosteroids in nanosterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria", PLoS One, 8(8), e72722.
DOI
|
| 68 |
Zhou, X., Li, Q., Yin, Y., Chen, Y. and Lin, J. (2008), "Identification of medicinal Ganoderma species based on PCR with specific primers and PCR-RFLP", Planta Med., 74(2), 197-200.
DOI
|
| 69 |
Zolle, I., Hossain, F., Rhodes, B.A. and Wagner, H.N., Jr. (1970), "Human serum albumin millimicrospheres for studies of the reticuloendothelial system", J. Nucl. Med., 11, 379-380.
|
| 70 |
Ezpeleta, I., Irache, J.M., Stainmesse, S., Chabenat, C., Gueguen, J., Popineau, Y. and Orecchioni, A.M. (1996b), "Gliadin nanoparticles for the controlled release of all-trans retinoic acid", Int. J. Pharm., 131(2), 191-200.
DOI
|
| 71 |
Fattal, E. and Vauthier, C. (2002), "Nanoparticles as drug delivery systems", In: Encyclopedia of Pharmaceutical Technology, (J. Swarbrick, J.C. Boylan Eds.), Marcel Dekker, New York, NY, USA, pp. 1864-1882.
|
| 72 |
Florindo, H.F., Pandit, S., Lacerda, L., Goncalves, L.M.D., Alpar, H.O. and Almeida, A.J. (2009), "The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles", Biomaterials, 30(5), 879-891.
DOI
|
| 73 |
Fernandez, L., Gonzalez, M., Cerecetto, H., Santo, M. and Silber, J.J. (2006), "Solubilization and release properties of dendrimers. Evaluation as prospective drug delivery systems", Supramol. Chem., 18(8), 633-643.
DOI
|
| 74 |
Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N. and Benita, S. (1989), "Nanocapsule formation by interfacial deposition following solvent displacement", Int. J. Pharm., 55(1), R1-R4.
DOI
|
| 75 |
Florence, A.T., Hillery, A.M., Hussain, N. and Jani, P.U. (1995), "Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate", J. Control. Release, 36(1-2), 39-46.
DOI
|
| 76 |
Foger, F., Noonpakdee, W., Loretz, B., Joojuntr, S., Salvenmoser, W., Thaler, M. and Bernkop-Schnurch, A. (2006), "Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles", Int. J. Pharm., 319(1-2), 139-146.
DOI
|
| 77 |
Gbadamosi, J.K., Hunter, A.C. and Moghimi, S.M. (2002), "PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance", FEBS Lett., 532(3), 338-344.
DOI
|
| 78 |
Fouarge, M., Dewulf, M., Couvreur, P., Rolland, M. and Vranckx, H. (1989), "Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis", J. Microencapsul., 6(1), 29-34.
DOI
|
| 79 |
Frechet, J.M.J. (1994), "Functional polymers and dendrimers: Reactivity, molecular architecture, and interfacial energy", Science, 263(5154), 1710-1715.
DOI
|
| 80 |
Fresta, M., Fontana, G., Bucolo, C., Cavallo, G., Giammona, G. and Puglisi, G. (2001), "Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphereencapsulated acyclovir", J. Pharm. Sci., 90(3), 288-297.
DOI
|
| 81 |
Gomez, S., Gamazo, C., San Roman, B., Vauthier, C., Ferrer, M. and Irache, J.M. (2006), "Development of a novel vaccine delivery system based on Gantrez nanoparticles", J. Nanosci. Nanotechnol., 6(9-10), 3283-3289.
DOI
|
| 82 |
Gomez, S., Gamazo, C., San Roman, B., Ferrer, M., Sanz, M.L., Espuelas, S. and Irache, J.M. (2008), "Allergen immunotherapy with nanoparticles containing lypopolysaccharide from Brucella ovis", Eur. J. Pharm. Biopharm., 70(3), 711-717.
DOI
|
| 83 |
Gomez, S., Gamazo, C., San Roman, B., Grau, A., Espuelas, S., Ferrer, M., Sanz, M.L. and Irache, J.M. (2009), "A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne", J. Immunol. Methods, 348(1-2), 1-8.
DOI
|
| 84 |
Gradishar, W.J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M. and O'Shaughnessy, J. (2005), "Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer", J. Clin. Oncol., 23(31), 7794-7803.
DOI
|
| 85 |
Huynh, N.T., Passirani, C., Saulnier, P. and Benoit, J.P. (2009), "Lipid nanocapsules: A new platform for nanomedicine", Int. J. Pharm., 379(2), 201-209.
DOI
|
| 86 |
Greco, F. and Vicent, M.J. (2009), "Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines", Adv. Drug Deliv. Rev., 61(13), 1203-1213.
DOI
|
| 87 |
Green, M.R., Manikhas, G.M., Orlov, S., Afanasyev, B., Makhson, A.M., Bhar, P. and Hawkins, M.J. (2006), "Abraxane, a novel cremophor-free, albuminbound particle form of paclitaxel for the treatment of advanced nonsmall-cell lung cancer", Ann. Oncol., 17(8), 1263-1268.
DOI
|
| 88 |
Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R. (1994), "Biodegradable long-circulating polymeric nanospheres", Science, 263(5153), 1600-1603.
DOI
|
| 89 |
Gregoriadis, G. and Ryman, B.E. (1972), "Lysosomal localization of  -fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders", Biomech. J., 129(1), 123-133.
|
| 90 |
Gurny, R., Peppas, N.A., Harrington, D.D. and Banker, G.S. (1981), "Development of biodegradable and injectable lattices for controlled release of potent drugs", Drug Dev. Ind. Pharm., 7(1), 1-25.
DOI
|
| 91 |
Joe, Y.H., Park, D.H. and Hwang, J. (2016), "Evaluation of Ag nanoparticle coated air filter against aerosolized virus: Anti-viral efficiency with dust loading", J. Hazard Mater., 301, 547-553.
DOI
|
| 92 |
Jung, G., Brandl, M., Eisner, W., Fraunberger, P., Reifenberger, G., Schlegel, U., Wiestler, O.D., Reulen, H.J. and Wilmanns, W. (2001), "Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ t-cell activation and therapeutic efficacy", Int. J. Cancer, 91(2), 225-230.
DOI
|
| 93 |
Kwon, G.S. (2003), "Polymeric micelles for delivery of poorly water-soluble compounds", Crit. Rev. Ther. Drug Carrier Syst., 20(5), 357-403.
DOI
|
| 94 |
Klajnert, B. and Bryszewska, M. (2001), "Dendrimers: Properties and applications", Acta Biochemica Polonica, 48(1), 199-208.
|
| 95 |
Kreuter, J. (1978), Book Chapter: New Generation Vaccines; Volume 261 of the series NATO ASI Series, Nanoparticles as Potent Adjuvants for Vaccines, pp. 73-81.
|
| 96 |
Kumari, A., Yadav, S.K. and Yadav, S.C. (2010), "Biodegradable polymeric nanoparticles based drug delivery systems", Colloid Surf. B: Biointerf., 75(1), 1-18.
DOI
|
| 97 |
Le Buanec, H., Vetu, C., Lachgar, A., Benoit, M.A., Gillard, J., Paturance, S., Aucouturier, J., Gane, V., Zagury, D. and Bizzini, B. (2001), "Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes", Biomed. Pharmacother, 55(6), 316-320.
DOI
|
| 98 |
Kumar, R., Ray, P.C., Datta, D., Bansal, G.P., Angov, E. and Kumar, N. (2015), "Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles", Vaccine, 33(39), 5064-5071. DOI: 10.1016/j.vaccine.2015.08.025
DOI
|
| 99 |
Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R. and Levy, R.J. (1998), "Arterial uptake of biodegradable nanoparticles: Effect of surface modifications", J. Pharm. Sci., 87(10), 1229-1234.
DOI
|
| 100 |
Lasic, D.D. (1998), "Novel applications of liposomes", Trends Biotechnol., 16(7), 307-321.
DOI
|
| 101 |
Le Buanec, H., Vetu, C., Lachgar, A., Benoit, M.A., Gillard, J., Paturance, S., Aucoututier, J., Gane, V., Zaguri, D., Miyake, A., Akagi, T., Enose, Y., Ueno, M., Kawamura, M., Horiuchi, R., Hiraishi, R., Adachi, M., Srizawa, T., Narayan, O., Akshi, M., Baba, M. and Hayami, M. (2004), "Induction of HIVspecific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques", J. Med. Virol., 73(3), 368-377.
DOI
|
| 102 |
Merisko-Liversidge, E.M. and Liversidge, G.G. (2008), "Drug nanoparticles: Formulating poorly watersoluble compounds", Toxicol. Pathol., 36(1), 43-48.
DOI
|
| 103 |
Agueros, M., Ruiz-Gaton, L., Vauthier, C., Bouchemal, K., Espuelas, S., Ponchel, G. and Irache, J.M. (2015), "Combined hydroxypropyl--cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel", Eur. J. Pharm. Sci., 38(4), 405-413.
DOI
|
| 104 |
Agrawal, S.K., Sanabria-DeLong, N., Coburn, J.M., Tew, G.N. and Bathia, S.R. (2006), "Novel drug release profiles from micellar solutions of PLAPEOPLA triblock copolymers", J. Control. Release, 112(1), 64-71.
DOI
|
webmaster
